Literature DB >> 17578467

Bipolar plasmakinetic technology for the treatment of symptomatic benign prostatic hyperplasia: evidence beyond marketing hype?

Riccardo Autorino1, Marco De Sio, Massimo D'Armiento.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17578467     DOI： 10.1111/j.1464-410X.2007.07042.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  4 in total

Review 1.  Plasmakinetic resection technology for the treatment of benign prostatic hyperplasia: evidence from a systematic review and meta-analysis.

Authors:  Sheng Li; Joey S W Kwong; Xian-Tao Zeng; Xiao-Lan Ruan; Tong-Zu Liu; Hong Weng; Yi Guo; Chang Xu; Jin-Zhu Yan; Xiang-Yu Meng; Xing-Huan Wang
Journal:  Sci Rep       Date:  2015-07-09       Impact factor: 4.379

2.  A prospective randomised controlled study comparing bipolar plasma vaporisation of the prostate to monopolar transurethral resection of the prostate.

Authors:  Ahmed M Elsakka; Hssan H Eltatawy; Khaled H Almekaty; Ahmed R Ramadan; Tarik A Gameel; Yasser Farahat
Journal:  Arab J Urol       Date:  2016-11-02

3.  Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction.

Authors:  Cameron Edwin Alexander; Malo Mf Scullion; Muhammad Imran Omar; Yuhong Yuan; Charalampos Mamoulakis; James Mo N'Dow; Changhao Chen; Thomas Bl Lam
Journal:  Cochrane Database Syst Rev       Date:  2019-12-03

4.  Monopolar versus bipolar transurethral resection of prostate for benign prostatic hyperplasia: Operative outcomes and surgeon preferences, a real-world scenario.

Authors:  Vijay Kumar Sarma Madduri; Malay Kumar Bera; Dilip Kumar Pal
Journal:  Urol Ann       Date:  2016 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.